Dr. Julia Kirshner

zPREDICTA

Reconstructing human tissue for more accurate testing of anti-cancer therapeutics

Dr Julia Kirshner, Founder and CEO zPREDICTA, discusses her team's aims to develop laboratory models that represent human disease for more accurate testing of anti-cancer therapeutics. zPREDICTA has created a system that allow the accurate reconstruction of human tissue so you can predict how drugs will work in a patient. zPREDICTA achieves this by using patient samples that are grown in a culture system and running combination treatments that patients will receive in the clinic. Join this webinar with Dr. Kirshner on automating tumor-specific 3D cultures for anti-cancer drug screening >>



LIKE 2


Dr. Julia Kirshner
SLAS

Dr. Julia Kirshner

Biography

Dr. Julia Kirshner gained... More
Follow Julia

Dr. Julia Kirshner

zPREDICTA

Dr. Julia Kirshner gained her Ph.D. in molecular and cell biology at the City of Hope Graduate School of Biological Sciences in 2003. Following her Ph.D., Kirshner went on to become an Assistant Professor at Purdue University. In 2014, Kirshner founded zPREDICTA, a company that uses patient-derived 3D culture models to test anti-cancer therapeutics.